The effect of CYP2C19 gene polymorphism and clopidogrel dose on clinical outcomes in Asian populations with CAD receiving antiplatelet therapy

被引：0
|
作者：
Liu, W. [1 ]
Xi, Z. W. [1 ]
Zhou, Y. J. [1 ]
机构：
[1] Beijing Anzhen Hosp, Caridiol, Beijing, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2867
引用
收藏
页码：613 / 613
页数：1
相关论文
共 50 条
  • [1] The effect of CYP2C19 gene polymorphism on clinical outcomes in patients with CAD receiving antiplatelet therapy
    Liu, W.
    Xi, Z. W.
    Zhou, Y. J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 837 - 837
  • [2] The impact of CYP2C19 gene polymorphism on the antiplatelet effect of clopidogrel and ticlopidine; the efficacy of ticlopidine on the non-responders of clopidogrel with CYP2C19 gene polymorphism
    Ishiguro, H.
    Asai, T.
    Umemoto, N.
    Sumida, A.
    Shimizu, K.
    Murohara, T.
    Maeda, A.
    Ando, H.
    Fujimura, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 968 - 968
  • [3] Impact of the CYP2C19 Gene Polymorphism on Clopidogrel Personalized Drug Regimen and the Clinical Outcomes
    Chen, Keguang
    Zhang, Rui
    Liu, Huanjun
    Guo, Xi
    Li, Pingli
    Liu, Xuehong
    CLINICAL LABORATORY, 2016, 62 (09) : 1773 - 1780
  • [4] Different Influences of CYP2C19 Gene Polymorphisms on Antiplatelet Effect of Clopidogrel and Ticlopidine
    Asai, Toru
    Ishiguro, Hisaaki
    Umemoto, Norio
    Morishima, Mikio
    Harata, Syuji
    Shimizu, Kiyokazu
    Murohara, Toyoaki
    Maeda, Akimitsu
    Ando, Hitoshi
    Fujimura, Akio
    CIRCULATION, 2010, 122 (21)
  • [5] CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients
    Yang Jie
    Zhao Hong-Dong
    Tan Jie
    Ding Yun-Long
    Zou Jian-Jun
    PHARMAZIE, 2013, 68 (03): : 183 - 186
  • [6] CYP2C19 Genetic Polymorphism, Rabeprazole and Esomeprazole Have no Effect on the Antiplatelet Action of Clopidogrel
    El-Halabi, Mustapha M.
    Zgheib, Nathalie
    Mansour, Nabil M.
    Malli, Ahmad
    Ghaith, Ola A.
    Mahfouz, Rami
    Alam, Samir
    Sharara, Ala I.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (01) : 41 - 49
  • [7] Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping
    Coons, James C. C.
    Stevenson, James M. M.
    Patel, Ami
    Smith, A. J. Conrad
    Prebehalla, Linda
    Empey, Philip E. E.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [8] CYP2C19*2 polymorphism and clopidogrel resistance
    Joob, Beuy
    Wiwanitkit, Viroj
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 (04): : 505 - 505
  • [9] Impact of CYP2C19 Polymorphisms on the Antiplatelet Effect of Clopidogrel in an Actual Clinical Setting in Japan
    Jinnai, Toshikazu
    Horiuchi, Hisanori
    Makiyama, Takeru
    Tazaki, Junichi
    Tada, Tomohisa
    Akao, Masaharu
    Ono, Koh
    Hoshino, Kozo
    Naruse, Yumiko
    Takahashi, Kanako
    Watanabe, Haruyo
    Kita, Toru
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2009, 73 (08) : 1498 - 1503
  • [10] The effect of CYP2C19 and CYP2C9 polymorphism on the pharmacodynamics of clopidogrel
    Jiang, Juanjuan
    Tian, Lei
    Han, Lulu
    Yan, Yan
    Huang, Yiling
    Liu, Hong
    Xie, Shuang
    Li, Yishi
    CARDIOLOGY, 2011, 120 : 30 - 31
12345